<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public" slc-id="S1-TAM23E29-VS7-TL-81G"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 S2672 IS: Improving Development and Distribution of Diagnostic Tests Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2023-07-27</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>118th CONGRESS</congress><session>1st Session</session><legis-num>S. 2672</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20230727">July 27, 2023</action-date><action-desc><sponsor name-id="S394">Ms. Smith</sponsor> (for herself and <cosponsor name-id="S252">Ms. Collins</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To require the Secretary of Health and Human Services to develop a strategic framework to improve the development and distribution of diagnostic tests in response to chemical, biological, radiological, or nuclear threats.</official-title></form><legis-body><section id="idcddc0b92912843569c98019f4591508d" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Improving Development and Distribution of Diagnostic Tests Act</short-title></quote>.</text></section><section id="ide02e64925e0242888b2c138cd8e0a240"><enum>2.</enum><header>Improving development and distribution of diagnostic tests</header><text display-inline="no-display-inline">Section 319B of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-2">42 U.S.C. 247d–2</external-xref>) is amended to read as follows:</text><quoted-block style="OLC" display-inline="no-display-inline" id="idBB68919D7FF246BABF35397BC00616A3"><section id="idbd65ae85122b4860b2155163f6024635"><enum>319B.</enum><header>Improving development and distribution of diagnostic tests</header><subsection id="idcee4a2b97792406bb32a74120d7f54b8"><enum>(a)</enum><header>Framework</header><text>The Secretary shall develop, make publicly available not later than 1 year after the date of enactment of the <short-title>Improving Development and Distribution of Diagnostic Tests Act</short-title>, and update not less frequently than every 3 years thereafter, a strategic framework for the rapid development, validation, authorization, manufacture, procurement, and distribution of diagnostic tests, and for rapid scaling of testing capacity, in response to chemical, biological, radiological, or nuclear threats, including infectious diseases for which a public health emergency is declared under section 319, or that has significant potential to cause such a public health emergency. Such strategic framework shall take into consideration—</text><paragraph id="id8a6ef2cc3f0d49f7b6af8f7b58a43f03"><enum>(1)</enum><text>domestic capacity, including any such capacity established through partnerships with public and private entities pursuant to subsection (c), to support the development, validation, authorization, manufacture, procurement, and distribution of tests;</text></paragraph><paragraph id="idd462bdf0ed1a437fb65aa4e4ea32133e"><enum>(2)</enum><text>novel technologies and platforms that may be used to improve testing capabilities, including high-throughput laboratory diagnostics, and point-of-care diagnostics, and any such technologies to improve the accessibility of such tests, and facilitate the development and manufacture of diagnostic tests;</text></paragraph><paragraph id="id9bbb372101624883af4feabcef4460bf"><enum>(3)</enum><text>medical supply needs related to testing, including diagnostic testing, equipment, supplies, and component parts, and any potential vulnerabilities related to the availability of such medical supplies and related planning, consistent with section 2811(b)(4)(J);</text></paragraph><paragraph id="id31a9313cd68a4793bce94aac99039b06"><enum>(4)</enum><text>strategies for the rapid and efficient distribution of tests locally, regionally, or nationwide and scaling laboratory testing capacity; and</text></paragraph><paragraph id="idad4b38b6adbd41b28f56746f3a340a6e"><enum>(5)</enum><text>assessing such strategies through drills and operational exercises carried out under section 2811(b)(4)(G), as appropriate.</text></paragraph></subsection><subsection id="idea891e27bdc5419fbab82b1258658f62"><enum>(b)</enum><header>Coordination</header><text>To inform the development and update of the framework under subsection (a), and in carrying out activities to implement such framework, the Secretary shall coordinate with industry, States, local governmental entities, Indian Tribes and Tribal organizations, Urban Indian organizations, and other relevant public and private entities.</text></subsection><subsection id="id6080fbc63ace43f7b19350d8a5b3d2ad"><enum>(c)</enum><header>Capacity building</header><text>The Secretary may contract with public and private entities, as appropriate, to increase domestic capacity in the rapid development, validation, authorization, manufacture, procurement, and distribution of diagnostic tests, as appropriate, to State, local, and Tribal health departments and other appropriate entities for immediate public health response activities to address an infectious disease with respect to which a public health emergency is declared under section 319, or that has significant potential to cause such a public health emergency.</text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></section></legis-body></bill> 

